Cancer research in the United States: Dying by a thousand paper cuts
The authors discuss cancer research in the United States and the implications of bureaucratic burdens on the conduct and cost of research and, consequently, the cost of drugs and health care. They propose potential remedial solutions.
No comments:
Post a Comment